North America Non-Invasive Aesthetic Treatment Markets, 2021-2028: Integration of Telemedicine with Medical Aesthetic Treatment & Technological Upgrades and Proliferation of Medical Tourism - ResearchAndMarkets.com

2022-08-13 14:05:32 By : Ms. Amy Xia

DUBLIN, April 01, 2022--(BUSINESS WIRE)--The "North America Non-Invasive Aesthetic Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Procedure (Injectables, Skin Rejuvenation, and Others) and End User (Hospitals, Clinics and Medical Spas, and Others)" report has been added to ResearchAndMarkets.com's offering.

The injectables segment by diagnosis is estimated to lead the market growth during the forecast period.

North America non-invasive aesthetic treatment market is expected to reach US$ 8,085.74 million by 2028 from US$ 3,126.34 million in 2021; it is estimated to grow at a CAGR of 14.5% from 2021 to 2028.

The report highlights trends prevailing in the North America non-invasive aesthetic treatment market and the factors driving market along with those that act as hindrances.

The North America non-invasive aesthetic treatment market based on the procedure was segmented into injectables, skin rejuvenation, and others. In 2020, the injectables segment held the largest share of the market, and same segment is expected to grow at the fastest rate during the coming years.

Non-invasive aesthetic treatments have gained popularity in the past few years due to advantages such as minimal downtime, no scars, low cost, and less complications. The popularity and acceptance of these procedures is mainly attributed to their non-invasiveness. Besides, it has been proved that the accuracy rate of minimally invasive surgeries is greater than that of open surgeries.

Therefore, the advantages of minimally invasive procedures over conventional surgery - such as faster recovery, reduced pain, and shortened hospital stays, and greater efficiency rate - contribute to the non-invasive aesthetic treatment market growth. As per the American Society for Aesthetic Plastic Surgery (ASAPS), in 2018, ~3.8 million minimally invasive cosmetic operations were performed in the US in people with age 55 and above. T

he advancements in nonsurgical technologies and unveiling of new surgery options have made aesthetics accessible to people. For example, the advantages of laser procedures have attracted younger people to improve their skin conditions, modify body parts, and correct their physical posture. Therefore, rising acceptance of non-invasive aesthetic/cosmetic procedures is driving the growth of the North America non-invasive aesthetic treatment market. Several government initiatives are helping in creating awareness regarding non-invasive aesthetic procedures among people, which is also boosting the market growth.

North America is highly affected due to the COVID-19 outbreak pandemic. In the US, due to an increasing number of infected patients, healthcare professionals and leading organizations distract the flow of healthcare resources from research & development to primary care, which is slowing down the process of innovation.

In addition, the COVID-19 pandemic is perplexing healthcare institutions in the region with unprecedented operational and clinical challenges with diagnostics and bed availability. Moreover, high priorities for the diagnosis and treatment of COVID-19 are leading to decline in non-invasive aesthetic treatment, which is restraining the growth of the North America non-invasive aesthetic treatment market up to certain extent.

The growth of the market is attributed to some key driving factors such as the increasing volume of funding activities for various research studies and other applications, and declining cost of sequencing procedures is expected to boost the sequencing reagents market. However, dearth of skilled professionals is expected to obstruct the growth of the market to a certain extent during the forecast years.

Rising Number of Non-Invasive Aesthetic/Cosmetic Procedures Performed Every Year

Surge in Awareness About Cosmetic Procedures Among Consumers

Availability of Technologically Advanced Products

Clinical Risks and Complications Associated with Medical Aesthetic Procedures

Technological Upgrades and Proliferation of Medical Tourism

Integration of Telemedicine with Medical Aesthetic Treatment

Johnson and Johnson Services, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/ogig0t

View source version on businesswire.com: https://www.businesswire.com/news/home/20220401005218/en/

ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

The market is unstable. Your portfolio doesn’t need to be.

Retirees and those seeking secure income got two items of very good news this week, though you may only have heard about one. July’s inflation came in below fears (although a debate now rages on what the “real” inflation rate is—more on that below). Meanwhile, your ability to earn a guaranteed rate of return on risk-free investments, regardless of what happens to inflation, actually went up.

John Mackey is bowing out in the battle between CEOs and a new generation entering the workforce, but as he told "Reason," he’s not leaving silently.

On Friday, five of China's biggest state firms announced their exit from Wall Street. More delistings could be on the way as Washington and Beijing remained embroiled in a dispute over audit rules for U.S.-listed Chinese companies.

Rogers knows how to survive — and thrive — in turbulent times.

Inflation is still near multi-decade highs. Mr. Wonderful is using these stocks to fight back.

SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the second quarter ended June 30, 2022. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. All results for the second quarter of 2021 exclude the subsequent acquisitions of Inner Spirit Holdings ("Spiritleaf") and Alcanna Inc. ("Alcanna"), which closed on July 20, 2021, and March 31, 2022, respectively.

Many semiconductor stocks slumped this year as investors fretted over concerns about slowing sales of PCs and smartphones, the potential overproduction of chips in response to the global chip shortage, and more conservative enterprise spending in a tougher macro environment. As a result, the Philadelphia Semiconductor Sector index has declined about 24% this year as the S&P 500 retreated just 12%.

The analysts covering Veru Inc. ( NASDAQ:VERU ) delivered a dose of negativity to shareholders today, by making a...

Johnson & Johnson stock is hitting its lowest level since March. Here's where it's a steal of a deal.

The entrepreneur Mark Cuban just took a stand in a debate that's hotly controversial in business circles and Congress.

Inflation has been making headlines all year, and rightly so; it’s at 40-year high levels, driven by sharp increases in the prices of gasoline and diesel fuels. But oil and its various refined products have come down in recent weeks, and so – the July inflation numbers weren’t as bad as had been feared. The overall year-over-year price increase for the month came to 8.5%, still awful, but less than the 8.7% economists had been predicting. Markets these days are rallying in response. Whether this

The S&P 500’s initial surge on Thursday to fresh three-month highs fizzled as the session wore on. The good news for bulls is that this is a Tom Jones rally, as in his famous song: “It’s not unusual.” Specifically, there is nothing superlative about the market’s, notably the Nasdaq’s, resurgence off its mid-June trough, suggests Bespoke Investment Group.

The super investor sees softness. But is sticking to her guns.

Where can you find extremely high-quality dividend stocks with high yields? Starting with this list of Dividend Aristocrats and narrowing it down to the higher-yielding ones can produce truly great dividend stocks. Below, we'll take a look at the three highest yielding Dividend Aristocrats now.

Financial planners share how much spouses should be able to comfortably spend from joint income.

Strong crude oil prices have once again brought investors' attention to energy stocks that have long been underperforming. The West Texas Intermediate crude oil price has largely been above $90 per barrel since the beginning of March. Here are two stocks that have delivered solid dividend growth consistently over the years, irrespective of oil prices.

Retirement planning can be tricky. These retirement planning tips can help you figure out the best way to save smarter if you're in your mid-60s and beyond.

I'm retired and living on Social Security and food stamps. I have all my money in two conservative retirement accounts. I cannot contribute any money to them. I plan on taking distributions in five years. What's the best course of … Continue reading → The post Ask An Advisor: I Live on Social Security and Food Stamps. Can I Protect My Investments in a Down Market? appeared first on SmartAsset Blog.

Tesla has given investors something to look forward to this coming week: a three-for-one stock split. As of the close of trading on Aug. 24, Tesla shareholders will get a “dividend” of two extra shares. The next day, Tesla stock will start trading at the new price—a third of what it used to be.